|
|
Reference
|
|
  
|
Anthonisen, N.R., Connett, J.E., Enright, P.L., Manfreda, J. (2002) Hospitalizations and mortality in the lung health study. American Journal of Respiratory and Critical Care Medicine, 166(3): 333-339
|
|
|
Appleton, S., Jones, T., Poole, P., Pilotto, L., Adams, R., Lasserson, T.J., Smith, B.J., Muhammed, J. (2006) Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, (3): CD001387
|
|
|
Bertoletti, L., Quenet, S., Mismetti, P., Hernández, L., Martín-Villasclaras, J.J., Tolosa, C., Valdés, M., Barrón, M., Todolí, J.A., Monreal, M. (2012) Clinical presentation and outcome of venous thromboembolism in COPD. European Respiratory Journal, 39(4): 862-868
|
|
|
Boschetto, P., Beghé, B., Fabbri, L.M., Ceconi, C. (2012) Link between chronic obstructive pulmonary disease and coronary artery disease: Implication for clinical practice. Respirology, 17(3): 422-431
|
|
|
Brekke, P.H., Omland, T., Smith, P., Søyseth, V. (2008) Underdiagnosis of myocardial infarction in COPD: Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation. Respiratory Medicine, 102(9): 1243-1247
|
|
|
Bursi, F., Vassallo, R., Weston, S.A., Killian, J.M., Roger, V.L. (2010) Chronic obstructive pulmonary disease after myocardial infarction in the community. American Heart Journal, 160(1): 95-101
|
|
|
Calverley, P.M.A., Anderson, J.A., Celli, B., Ferguson, G.T., Jenkins, C., Jones, P.W., Crim, C., Willits, L.R., Yates, J.C., Vestbo, J. (2010) Cardiovascular events in patients with COPD: TORCH Study results. Thorax, 65(8): 719-725
|
|
|
Camiciottoli, G., Bigazzi, F., Magni, C., Bonti, V., Diciotti, S., Bartolucci, M., Mascalchi, M., Pistolesi, M. (2016) Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease, Volume 11: 2229-2236
|
|
|
Cao, C., Wang, R., Wang, J., Bunjhoo, H., Xu, Y., Xiong, W. (2012) Body mass index and mortality in chronic obstructive pulmonary disease: A meta-analysis. PLoS One, 7: 1-8
|
|
|
Ciric, Z., Stankovic, I., Pejcic, T., et al. (2013) Nutrition disorders and systemic inflammation in patients with chronic obstructive pulmonary disease. Med Glas, 10(2): 266-71, PMID: 23892843
|
|
|
Cui, H., Miao, D.M., Wei, M.Z., et al. (2012) Prevalence of cardiovascular disease in subjects hospitalized due to chronic obstructive pulmonary disease in Beijing from 2000 to 2010. J Geriatr Cardiol, 9(1): 5-10
|
|
|
de Lucas-Ramos, P., Izquierdo-Alonso, J.L., Rodriguez-Gonzalez, M.J.M., et al. (2008) Cardiovascular risk factors in chronic obstructive pulmonary disease: Results of the ARCE study. Arch Bronconeumol, 44: 233-241
|
|
|
Decramer, M.L., Hanania, N.A., Lötvall, J.O., Yawn, B. (2013) The safety of long-acting ß2-agonists in the treatment of stable chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease, 8: 53-64
|
|
|
Díez-Manglano, J., Barquero-Romero, J., Almagro, P., Cabrera, F.J., López, G.F., Montero, L., Soriano, J.B. (2014) COPD patients with and without metabolic syndrome: Clinical and functional differences. Internal and Emergency Medicine, 9(4): 419-425
|
|
|
Divo, M., Cote, C., de Torres, J.P., Casanova, C., Marin, J.M., Pinto-Plata, V., Zulueta, J., Cabrera, C., Zagaceta, J., Hunninghake, G., Celli, B. (2012) Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 186(2): 155-161
|
|
|
Donaldson, G.C., Hurst, J.R., Smith, C.J., Hubbard, R.B., Wedzicha, J.A. (2010) Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest, 137(5): 1091-1097
|
|
|
Etminan, M., Jafari, S., Carleton, B., Fitzgerald, J.M. (2012) Beta-blocker use and COPD mortality: A systematic review and meta-analysis. BMC Pulmonary Medicine, 12(1): 48-48
|
|
|
Finkelstein, J., Cha, E., Scharf, S.M. (2009) Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. International Journal of Chronic Obstructive Pulmonary Disease, 4: 337-49
|
|
|
Ford, E.S., Wheaton, A.G., Mannino, D.M., Presley-Cantrell, L., Li, C., Croft, J.B. (2012) Elevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: A cross-sectional study of the National Health and Nutrition Examination Survey from 2007-2010. Respiratory Research, 13(1): 115-115
|
|
|
García-Olmos, L., Alberquilla, Á., Ayala, V., García-Sagredo, P., Morales, L., Carmona, M., de Tena-Dávila, M.J., Pascual, M., Muñoz, A., Salvador, C.H., Monteagudo, J.L. (2013) Comorbidity in patients with chronic obstructive pulmonary disease in family practice: A cross sectional study. BMC Family Practice, 14(1): 11-11
|
|
|
Held, C., Iqbal, C., Lear, S.A., et al. (2012) Physical activity levels, ownership of goods promoting sedentary behaviour and risk of myocardial infarction: Results of the INTERHEART study. Eur Heart J, 33(4): 452-66
|
|
|
Hogg, J.C., Timens, W. (2009) The pathology of chronic obstructive pulmonary disease. Annual Review of Pathology: Mechanisms of Disease, 4(1): 435-459
|
|
|
Huiart, L., Ernst, P., Ranoui, X., et al. (2005) Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD. European Respiratory Journal, 25(4): 634-639
|
|
|
Kido, T., Tamagawa, E., Bai, N., Suda, K., Yang, H.C., Li, Y., Chiang, G., Yatera, K., Mukae, H., Sin, D.D., van Eeden, S.F. (2011) Particulate matter induces translocation of IL-6 from the lung to the systemic circulation. American Journal of Respiratory Cell and Molecular Biology, 44(2): 197-204
|
|
|
Lahousse, L., Loth, D.W., Joos, G.F., Hofman, A., Leufkens, H.G.M., Brusselle, G.G., Stricker, B.H. (2013) Statins, systemic inflammation and risk of death in COPD: The Rotterdam study. Pulmonary Pharmacology & Therapeutics, 26(2): 212-217
|
|
|
Mancini, G.B. J., Etminan, M., Zhang, B., Levesque, L.E., Fitzgerald, J. M., Brophy, J.M. (2006) Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. Journal of the American College of Cardiology, 47(12): 2554-2560
|
|
|
Marchetti, N., Ciccolella, D.E., Jacobs, M.R., Crookshank, A., Gaughan, J.P., Kashem, M.A., Bove, A.A., Criner, G.J. (2011) Hospitalized acute exacerbation of COPD impairs flow and nitroglycerin-mediated peripheral vascular dilation. COPD: Journal of Chronic Obstructive Pulmonary Disease, 8(2): 60-65
|
|
|
McMurray, J.J.V., Adamopoulos, S., Anker, S.D., Auricchio, A., Bohm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., Gomez-Sanchez, M.A., Jaarsma, T., Kober, L., Lip, G.Y.H., Maggioni, A.P., Parkhomenko, A., Pieske, B.M., Popescu, B.A., Ronnevik, P.K. (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology: Developed in collaboration with the. European Heart Journal, 33(14): 1787-1847
|
|
|
Morgan, A.D., Zakeri, R., Quint, J.K. (2018) Defining the relationship between COPD and CVD: What are the implications for clinical practice?. Therapeutic Advances in Respiratory Disease, 12: 1-16
|
|
|
Mortensen, E.M., Copeland, L.A., Pugh, M.J.V., Restrepo, M.I., de Molina, R.M., Nakashima, B., Anzueto, A. (2009) Impact of statins and ACE inhibitors on mortality after COPD exacerbations. Respiratory Research, 10(1): 45-45
|
|
|
Mullerova, H., Agusti, A., Erqou, S., et al. (2013) Cardiovascular comorbidity in chronic obstructive pulmonary disease: Systematic literature review. Chest, 144: 1163-78
|
|
|
O'Donnell, C.J., Elosua, R. (2008) Cardiovascular risk factors: Insights from Framingham heart study. Revista Española de Cardiología (English Edition), 61(3): 299-310
|
|
1
|
Poulain, M., Doucet, M., Major, G.C., Drapeau, V., Sériès, F., Boulet, L., Tremblay, A., Maltais, F. (2006) The effect of obesity on chronic respiratory diseases: Pathophysiology and therapeutic strategies. Canadian Medical Association Journal, 174(9): 1293-1299
|
|
|
Quint, J. (2017) The Relationship between COPD and cardiovascular disease. Tanaffos, 16(Suppl 1): S16-S17, PMID: 29158754
|
|
|
Radovic, M., Ristic, L., Ciric, Z., Dinic, R.V., Stankovic, I., Pejcic, T., Rancic, M., Bogdanovic, D. (2016) Changes in respiratory function impairment following the treatment of severe pulmonary tuberculosis: Limitations for the underlying COPD detection. International Journal of Chronic Obstructive Pulmonary Disease, 11(1): 1307-16
|
|
|
Reed, R.M., Eberlein, M., Girgis, R.E., Hashmi, S., Iacono, A., Jones, S., Netzer, G., Scharf, S. (2012) Coronary artery disease is under-diagnosed and under-treated in advanced lung disease. American Journal of Medicine, 125(12): 1228.e13-1228.e22
|
|
|
Roca, M., Verduri, A., Corbetta, L., Clini, E., Fabbri, L.M., Beghé, B. (2013) Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease. European Journal of Clinical Investigation, 43(5): 510-521
|
|
|
Roversi, S., Roversi, P., Spadafora, G., Rossi, R., Fabbri, L.M. (2014) Coronary artery disease concomitant with chronic obstructive pulmonary disease. European Journal of Clinical Investigation, 44(1): 93-102
|
|
|
Schnell, K., Weiss, C.O., Lee, T., Krishnan, J.A., Leff, B., Wolff, J.L., Boyd, C. (2012) The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: A cross-sectional study using data from NHANES 1999-2008. BMC Pulmonary Medicine, 12(1): 26-26
|
|
|
Sevenoaks, M.J., Stockley, R.A. (2006) Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity: A common inflammatory phenotype?. Respiratory Research, 7(1): 70
|
|
|
Singh, D., Agusti, A., Anzueto, A., Barnes, P.J., Bourbeau, J., Celli, B.R., Criner, G.J., Frith, P., Halpin, D.M.G., Han, M., López, V.M. V., Martinez, F., Montes, de O.M., Papi, A., Pavord, I.D. (2019) Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: The GOLD science committee report 2019. European Respiratory Journal, 53(5): pii: 1900164
|
|
1 
|
Stanković, I., Ćirić, Z., Radović, M. (2011) Asthma exacerbations and viruses. Acta facultatis medicae Naissensis, vol. 28, br. 4, str. 241-244
|
|
|
van Eeden, S.F., Sin, D.D. (2008) Chronic obstructive pulmonary disease: A chronic systemic inflammatory disease. Respiration, 75(2): 224-238
|
|
|
Vestbo, J., Anderson, J., Brook, R.D., Calverley, P.M.A., Celli, B.R., Crim, C., Haumann, B., Martinez, F.J., Yates, J., Newby, D.E. (2013) The study to understand mortality and morbidity in COPD (SUMMIT) study protocol. European Respiratory Journal, 41(5): 1017-1022
|
|
|
Yuji, H., Toshiyuki, Y., Noritsugu, H., Ryuji, S., Hiroyuki, S., Takashi, I., Takayuki, M., Masato, M., Katsuyuki, T., Yuji, T., Kanji, F. (2011) Clinical and inflammatory factors associated with body mass index in elderly patients with chronic obstructive pulmonary disease. Geriatrics & Gerontology International, 11(1): 32-38
|
|
|
|
|